Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 179
Infectious Diseases Drugs 128
Genomics 113
Drug Discovery 79
Liver and Kidney Disorders Drugs 71
Cardiovascular Drugs 62
Immune Disorders Drugs 57
Pharmaceuticals 52
Biopharmaceuticals 44
Biotechnology 40
Clinical Trials 38
Leukemia Drugs 37
Lymphoma Drugs 31
Respiratory Drugs 28
HIV/AIDS Drugs 27
Musculoskeletal Disorders Drugs 26
Pharmaceutical Manufacturing 24
Enzymes 22
Pulmonary Medicine 20
Drug Delivery 17
Oncology 17
Allergy and Immunology 16
Central Nervous System Drugs 16
Infusions and Injectables 16
Vaccines 15
Infectious Disease Testing 14
Gastrointestinal Drugs 13
Hematological Drugs 13
Diagnostics 12
Endocrine and Metabolic Disorders Drugs 11
Sexual and Reproductive Health Drugs 10
Pharmaceutical Intermediates 8
Healthcare Services 8
Women's Health 8
Breast Cancer Drugs 8
Antibiotics 8
Optical Disorders Drugs 7
Stem Cells 7
Therapeutic Area 6
Lung Cancer Drugs 6
Hematology 6
Nanomedicine 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Needles and Syringes 5
Pediatrics 5
Generic Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
In Vitro Diagnostics 4
Analgesics 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Liver Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Anesthetic Drugs 3
Medical Devices 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Immunosuppressive Drugs 3
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
Home Testing and Home Healthcare 2
Healthcare 2
Managed Care 2
Optical 2
Blood Banking 2
Over the Counter (OTC) Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Cardiology 2
Urological Disorders Drugs 2
Neurology 1
Urology and Nephrology 1
E-Healthcare 1
Fertility Services 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Gastroenterology 1
Anatomy 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

1,047 Results (Page 29 of 53)
- Relevance
  Sort by

Schizophrenia Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Prescription Drugs - Global Strategic Business Report

 Report
November 2024
150 Pages
Global

From

€5531EUR$5,600USD£4,610GBP

Central Nervous System Collaboration and Licensing Deals 2019-2024

 Report
October 2024
500 Pages
Global

From

€3946EUR$3,995USD£3,289GBP

Sterile Injectable Drugs - Global Strategic Business Report

 Report
November 2024
194 Pages
Global

From

€5383EUR$5,450USD£4,487GBP

A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report

 Report
February 2023
255 Pages
Global

From

€2469EUR$2,500USD£2,058GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cystic Fibrosis Market by Drug Class, Route of Administration - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3502EUR$3,545USD£2,918GBP

€3891EUR$3,939USD£3,243GBP

Fungal Keratitis Treatment Market 2023-2027

 Report
October 2023
162 Pages
Global

From

€2469EUR$2,500USD£2,058GBP

Global TCR Therapy Market, 2022-2035: Distribution by Target Indication, Target Antigen, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
December 2022
363 Pages
Global

From

€4740EUR$4,799USD£3,951GBP

Global TROP2 Antibody Market, Drug Sales & Clinical Trials Outlook 2028

 Report
February 2023
110 Pages
Global

From

€2370EUR$2,400USD£1,976GBP

Europe Cell & Gene Therapy Market - Focused Insights 2024-2029

 Report
June 2024
103 Pages
Europe

From

€2173EUR$2,200USD£1,811GBP

Antibody Drug Conjugates Market Report 2022-2032

 Report
November 2022
434 Pages
Global

From

€4905EUR$5,140USD£3,950GBP

Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€4445EUR$4,500USD£3,704GBP

Antibiotics Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Inhaled Antibiotics Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Viral Vector Collaboration and Licensing Deals 2016-2024

 Report
November 2024
250 Pages
Global

From

€3946EUR$3,995USD£3,289GBP

Antifungal Drugs - Global Strategic Business Report

 Report
November 2024
179 Pages
Global

From

€5383EUR$5,450USD£4,487GBP

Antivirals Drug - Global Strategic Business Report

 Report
November 2024
172 Pages
Global

From

€5383EUR$5,450USD£4,487GBP

Anti-Infectives - Global Strategic Business Report

 Report
November 2024
116 Pages
Global

From

€5383EUR$5,450USD£4,487GBP

Cystitis - Pipeline Insight, 2024

 Clinical Trials
April 2024
80 Pages
Global

From

€1037EUR$1,050USD£864GBP

€1482EUR$1,500USD£1,235GBP

Cystic Fibrosis Therapeutics Market Report by Drug Class, Route of Administration, Distribution Channel, Regions and Company Analysis 2024-2032

 Report
June 2024
220 Pages
Global

From

€2262EUR$2,290USD£1,885GBP

1,047 Results (Page 29 of 53)
- 1
- 27
- 28
- 29
- 30
- 31

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.